Cancer

Title
A Study of the Combination of Chemotherapy and Dasatinib with or without Stem Cell Transplant on Acute Lymphoblastic Leukemia
Trial Number
203268011911
Number of Participants
85
Principal Investigator

Aileen Go

M.D.
Hematology/Oncology
Assistant Professor
Eligibility

Adults = 18 years of age with the following criteria may be eligible: morphologic diagnosis of acute lymphoblastic leukemia and Philadelphia chromosome-positive and/or BCR/ABL–positive. Please see the protocol for additional requirements.

Purpose

The purpose of this study is to find out what effects, good and/or bad, the investigational drug dasatinib has on you and your leukemia.

Enrollment

(708) 327-3308

MORE CLINICAL TRIALS

Clinical Trials

For more information call (888) LUHS-888.